ESR1 and breast cancer: To address whether EMT is involved in sensitivity to DOX treatment in breast cancer cells, cells with different phenotypes and ERα expression were incubated with DOX and the related epithelial and mesenchymal phenotypic biomarkers were characterized using western blots.